Martingale Asset Management’s Idexx Laboratories IDXX Stock Holding History

Martingale Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,198	Closed	-$12.7M	–	860
2022 Q1	$12.7M	Sell	23,198 -25,627	-52%	-$13.5M	0.19%	145
2021 Q4	$32.1M	Sell	48,825 -4,680	-9%	-$2.94M	0.41%	98
2021 Q3	$33.3M	Sell	53,505 -15,104	-22%	-$10.1M	0.43%	94
2021 Q2	$43.3M	Buy	68,609 +31,505	+85%	+$17.4M	0.49%	80
2021 Q1	$18.2M	Buy	37,104 +36,202	+4,014%	+$18.1M	0.21%	149
2020 Q4	$451K	Buy	+902	New	+$404K	0.01%	643
2019 Q1	–	Sell	-4,890	Closed	-$910K	–	1032
2018 Q4	$910K	Sell	4,890 -102	-2%	-$20.9K	0.01%	752
2018 Q3	$1.25M	Sell	4,992 -400	-7%	-$97.1K	0.01%	679
2018 Q2	$1.18M	Sell	5,392 -302	-5%	-$62.2K	0.01%	708
2018 Q1	$1.09M	Buy	5,694 +2,690	+90%	+$496K	0.01%	707
2017 Q4	$470K	Buy	3,004 +102	+4%	+$16.1K	0.01%	824
2017 Q3	$452K	Buy	2,902 +899	+45%	+$142K	0.01%	854
2017 Q2	$324K	Buy	+2,003	New	+$325K	﹤0.01%	875

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Martingale Asset Management's IDXX Position: Q2 2022 in Review

Martingale Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 23,198 shares — an estimated $12.7M sold.

Martingale Asset Management first reported a position in IDXX in Q2 2017 and held it in 13 quarters. The position peaked at $43.3M in Q2 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Martingale Asset Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Martingale Asset Management sold 23,198 Idexx Laboratories shares in Q2 2022, an estimated $12.7M.
Martingale Asset Management first reported a position in Idexx Laboratories in Q2 2017 and held it in 13 quarters.
Martingale Asset Management's Idexx Laboratories position peaked at $43.3M in Q2 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Martingale Asset Management's 13F filing for Q2 2022, filed 11 Aug 2022.